Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dengue fever
Manufacturing
Takeda taps India's Biological E to ramp up Qdenga manufacturing
The new partner will scale up to a capacity of 50 million doses a year, helping Takeda on its mission to produce 100 million doses a year by 2030.
Zoey Becker
Feb 27, 2024 11:33am
UPDATED: Takeda yanks FDA application for dengue vaccine Qdenga
Jul 11, 2023 11:26am
PAHO in early dengue vaccine pricing talks with Takeda
Apr 21, 2023 11:21am
Takeda unveils dengue vaccine pricing outlook after Brazil nod
Mar 21, 2023 11:56am
Takeda expands manufacturing in preparation for Qdenga launch
Jan 10, 2023 10:17am
Takeda's dengue vaccine scores crucial EU nod
Dec 8, 2022 11:48am